Detalhe da pesquisa
1.
Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors.
Immunol Rev
; 298(1): 117-133, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965719
2.
The antitumor activity of human Vγ9Vδ2 T cells is impaired by TGF-ß through significant phenotype, transcriptomic and metabolic changes.
Front Immunol
; 13: 1066336, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36741364
3.
BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
Cell Rep
; 36(2): 109359, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260935